The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCRF.L Regulatory News (SCRF)

  • There is currently no data for SCRF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Company Update

3 Apr 2020 07:00

RNS Number : 6635I
SME Credit Realisation Fund Limited
03 April 2020
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OR TO US PERSONS

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014.

*****

3 April 2020

SME Credit Realisation Fund Limited

(the "Company") 

Company Update

The Board provides the following update following its preliminary assessment of the potential implications of the COVID-19 pandemic.

Whilst the future performance of the Company's underlying loans may be adversely affected by COVID-19, in common with many other forms of corporate lending, the Board is pleased to report further positive progress in the Company's winding-down with returns of cash to shareholders of c. £22 million intended to be declared for payment in May 2020.

Returns to shareholders

The Company intends to continue returning surplus cash to shareholders on a quarterly basis; that is broadly speaking loan principal and interest receipts, less operating expenses, less leverage costs and repayments, less any FX margin reserve maintenance requirements.

Dividend declaration

The Company will pay a quarterly dividend of 1.3125 pence per share in May 2020. Details of the timetable for the dividend payment will be published in the next few days.

Compulsory partial redemption of Shares

In addition to the dividend, the Company will return approximately £18.5 million to shareholders by way of a compulsory partial redemption of shares. Again, further details of the partial redemption of shares will be published in the next few days.

The Company and its advisers will continue to review how and when capital is returned to shareholders, which may change over the course of time.

Delay to publication of the Company's NAV

As a result of the uncertainty caused by COVID-19 the Company has decided to delay the publication of its NAV as at 31 March 2020 which otherwise would have been released mid-April. The Company will publish the NAV when market conditions stabilise sufficiently to allow the establishment of detailed forward-looking assumptions based on evolving market data and thus facilitate the calculation of a reliable NAV.

Pending publication of the Company's NAV as at 31 March 2020, the Board has resolved to suspend share repurchases.

It is the Board's intention to be as transparent as possible with shareholders through this period of uncertainty and we will continue to provide updates at appropriate junctures.

Active risk management and focus on collections

The Board continues to work closely with its advisers and Funding Circle to manage the Company's portfolio and ensure that appropriate steps are being taken to mitigate risk and achieve the best outcome for both investors and borrowers.

The Company hedges USD and EUR exposure to GBP and maintains a prudent FX reserve margin which has been increased further in light of recent FX volatility; this reserve is actively monitored and maintained along with management of liquidity requirements deriving from other operating expenses and financial liabilities. The Company will continue to hedge USD and EUR exposure to GBP. The Company has provided additional detail on its current borrowings below under the section "Leverage".

Funding Circle has taken wide-ranging business contingency steps already and will continue to respond to COVID-19 as the environment develops. Funding Circle employees have successfully switched to working from home which has been readily facilitated by a pre-existing technology-focused infrastructure. Servicing, collections and recoveries capabilities have been materially enhanced with increased headcount and training as well as pre-emptive on-boarding of additional third party capacity should it be required.

Funding Circle's business model is built on the need for a well-functioning financial system for SME borrowers and lenders and is working to provide a flexible and pragmatic approach to its collections activities to both support borrowers and to protect investor returns, in line with governmental and regulatory guidance.

Portfolio disposals

The Company announced in early February 2020 that having run an auction process over the preceding months the Board were pursuing a potential sale of a portion of its assets. It is still the Company's intention to effect a sale of a portion of its assets and the Company continues to engage with potential buyers. That said, given the current market volatility and uncertainty caused by COVID-19, it is likely the asset sales shall be delayed, or may not proceed at all.

Leverage

As at 31 March 2020, the Company's outstanding borrowings were approximately £56 million on a look-through basis, which equates to a debt to equity ratio of 22% based on the Company's 31 December 2019 NAV of approximately £259 million. All of the Company's leverage facilities are in amortisation with the majority of cashflows from loans held within the respective SPVs being prioritised to reduce the Company's borrowings.

Transition to fair value accounting

As referenced in the Company's interim report published in December, the Company has, as a result of the Company's business model changing, with effect from its FY20/21 beginning 1 April 2020 moved to fair value accounting for the loans it holds. The Company therefore expects to publish its NAV from and including as at 30 June 2020 using fair value methodology, which will involve the application of a discount rate implied by market comparables to the expected cashflows from the Company's loan portfolio. Further details, including potential variance in NAV, will be disclosed in the Company's FY19/20 annual report scheduled for publication in July.

 

CONTACTS

Richard Boleat, Chairman

+44 (0) 1534 615 656

Richard.Boleat@smecreditrealisation.com

 

Secretary and Administrator

Sanne Group (Guernsey) Limited

+44 (0) 1481 739810

smecreditrealisation@sannegroup.com

 

Corporate Broker

Numis Securities

Nathan Brown

George Shiel

+44 (0) 207 260 1000

n.brown@numis.com

 

Investor Relations

IR@smecreditrealisation.com

 

Website

www.smecreditrealisation.com

 

The ISIN number of the Ordinary Shares is GG00BKX9MJ69, the SEDOL code is BKX9MJ6 and the TIDM is SCRF.

The LEI number of the Company is 549300ZQIYQVNIZGOW60.

 

 *****

ABOUT SME CREDIT REALISATION FUND LIMITED

The Company is a registered closed-ended collective investment scheme registered pursuant to the Protection of Investors (Bailiwick of Guernsey) Law, 1987, as amended and the Registered Collective Investment Scheme Rules 2018 issued by the Guernsey Financial Services Commission (''GFSC'').

 

*****

IMPORTANT NOTICES

This announcement contains "forward-looking" statements, beliefs or opinions. These forward-looking statements involve known and unknown risks and uncertainties, many of which are beyond the control of the Company and all of which are based on its directors' current beliefs and expectations about future events. Forward-looking statements are sometimes identified by the use of forward-looking terminology such as "believes", "expects", "may", "will", "could", "should", "shall", "risk", "intends", "estimates", "aims", "plans", "predicts", "projects", "continues", "assumes", "positioned" or "anticipates" or the negative thereof, other variations thereon or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events, assumptions or intentions. These forward-looking statements include all matters that are not historical facts. Forward-looking statements may and often do differ materially from actual results. They appear in a number of places throughout this announcement and include statements regarding the intentions, beliefs or current expectations of the Board or the Company with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business concerning, amongst other things, the financial performance, liquidity, prospects, growth and strategies of the Company. These forward-looking statements and other statements contained in this announcement regarding matters that are not historical facts involve predictions. No assurance can be given that such future results will be achieved; actual events or results may differ materially as a result of risks and uncertainties facing the Company. Such risks and uncertainties could cause actual results to vary materially from the future results indicated, expressed or implied in such forward-looking statements. The forward-looking statements contained in this announcement speak only as of the date of this announcement. Nothing in this announcement is, or should be relied on as, a promise or representation as to the future. The Company disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in its expectations or any change in events, conditions or circumstances on which such statements are based unless required to do so by applicable law, the Prospectus Rules, the Listing Rules or the Disclosure Rules and Transparency Rules of the FCA. No statement in this announcement is intended as a forecast or profit estimate.

Neither this announcement nor any copy of it may be made or transmitted into the United States of America (including its territories or possessions, any state of the United States of America and the District of Columbia) (the "United States"), or distributed, directly or indirectly, in the United States or to US Persons (as such term is defined in Regulation S under the US Securities Act of 1933, as amended (the "Securities Act"). Neither this announcement nor any copy of it may be taken or transmitted directly or indirectly into Australia, Canada, Japan or South Africa or to any persons in any of those jurisdictions, except in compliance with applicable securities laws. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian, Japanese or South African securities laws. The distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions. This announcement does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for securities in the United States, Australia, Canada, Japan or South Africa or in any jurisdiction to whom or in which such offer or solicitation is unlawful.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDBLLLBBZLLBBD
Date   Source Headline
21st Dec 201712:42 pmRNSScrip Dividend Circular
21st Dec 201712:41 pmRNSDividend Reference Share Price
18th Dec 20173:40 pmRNSC Share Conversion
14th Dec 20177:00 amRNSNet Asset Value(s)
8th Dec 20173:54 pmRNSHolding(s) in Company
8th Dec 20177:00 amRNSHalf-year Report
7th Dec 20171:57 pmRNSDividend Declaration
7th Dec 20171:54 pmRNSDirector Declaration
14th Nov 20175:09 pmRNSNet Asset Value(s)
13th Nov 201710:07 amRNSHolding(s) in Company
25th Oct 201711:18 amRNSIssue of Scrip Dividend Shares
13th Oct 20177:00 amRNSNet Asset Value(s)
28th Sep 201711:34 amRNSDividend Reference Share Price
27th Sep 20174:11 pmRNSScrip Dividend Circular
14th Sep 201710:22 amRNSDividend Declaration
13th Sep 20175:26 pmRNSDirector Declaration
13th Sep 20177:00 amRNSNet Asset Value(s)
6th Sep 20173:50 pmRNSResult of AGM
31st Aug 20174:10 pmRNSDirector Declaration
17th Aug 201711:20 amRNSHolding(s) in Company
14th Aug 20177:00 amRNSNet Asset Value(s)
10th Aug 201712:33 pmRNSNotice of AGM
1st Aug 20177:00 amRNSTotal Voting Rights
24th Jul 201711:39 amRNSIssue of scrip dividend shares
19th Jul 20174:46 pmRNSPublication of Suppl.Prospcts
19th Jul 201711:58 amRNSHolding(s) in Company
14th Jul 20177:00 amRNSNet Asset Value(s)
14th Jul 20177:00 amRNSAnnual Financial Report
29th Jun 20175:50 pmRNSDividend Reference Share Price
15th Jun 20175:02 pmRNSDividend Declaration
14th Jun 20177:00 amRNSNet Asset Value(s)
6th Jun 20177:00 amRNSHolding(s) in Company
5th Jun 20171:43 pmRNSPublication of Suppl.Prospcts
1st Jun 201711:45 amRNSAppointment of Alternate Director
25th May 201711:22 amRNSClarification of Investment Restrictions
18th May 20177:00 amRNSDirectorate Change
15th May 20177:00 amRNSNet Asset Value(s)
28th Apr 20177:00 amRNSTotal Voting Rights
26th Apr 20179:14 amRNSIssue of Scrip Dividend Shares
18th Apr 20172:47 pmRNSHolding(s) in Company
18th Apr 20177:00 amRNSNet Asset Value(s)
12th Apr 201710:11 amRNSAdmission of C Shares
7th Apr 20171:28 pmRNSResults of Placing
30th Mar 20176:25 pmRNSScrip Dividend Circular
30th Mar 20175:00 pmRNSDividend Reference Share Price
16th Mar 20179:43 amRNSC Share Placing
15th Mar 201710:51 amRNSDividend Declaration
14th Mar 20177:00 amRNSNet Asset Value(s)
15th Feb 20174:06 pmRNSHolding(s) in Company
14th Feb 20177:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.